N-linked galactose-containing glycan

N-linked galactose-containing glycans are complex carbohydrate modifications found on the asparagine residues of cell surface and secreted proteins, including those in the central nervous system (CNS)[1][3][5][6]. They are a subclass of N-linked glycans that feature galactose residues as major components of their antennae, following core glycan assembly in the endoplasmic reticulum and further processing in the Golgi apparatus[1][3][5]. These galactosylated glycans play key roles in regulating protein folding, stability, trafficking, and interactions, and they modulate the function of many neural glycoproteins and receptors, contributing to brain development, synaptic plasticity, cell adhesion, and immune cell interactions[1][2][4][6]. Aberrant galactosylation or broader N-linked glycosylation defects are linked to neurodegenerative disorders, cancers, and immunological diseases[1][4][6]. Unlike classical single targets such as receptors or enzymes, N-linked galactose-containing glycan is a structural feature/chemical modification rather than a discrete therapeutic target, protein, or receptor. This entry refers to a glycan structure, not a classical molecular target, and is not a defined gene/protein product. It is a biochemical modification found on a wide range of (mostly) glycoproteins[1][3][6]. No standard abbreviation exists, and this is not referred to as a receptor or enzyme. No approved drugs directly target galactose on N-glycans as a unique entity, though drugs may impact or be affected by overall glycosylation patterns. The specificity to CNS cell surfaces is purely descriptive; such structures are also found in other tissues, but have specialized roles in the CNS[1][2].

Other names

N-linked glycan with galactosegalactosylated N-glycancomplex N-glycan (galactose-terminated)